<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00035880</url>
  </required_header>
  <id_info>
    <org_study_id>ABX-CB-9906</org_study_id>
    <nct_id>NCT00035880</nct_id>
    <nct_alias>NCT00012077</nct_alias>
  </id_info>
  <brief_title>Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease</brief_title>
  <official_title>A Phase II/III, Multicenter, Open Label, Randomized Clinical Trial Evaluating ABX-CBL When Compared to Atgam as Second Line Therapy in Patients With Steroid Resistant Acute Graft Versus Host Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abgenix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sangstat Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Abgenix</source>
  <brief_summary>
    <textblock>
      Trial evaluating the improvement in survival at 180 days of two therapies (Atgam versus
      ABX-CBL, a monoclonal antibody) in patients with acute graft versus host disease that does
      not respond to steroid therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1999</start_date>
  <completion_date>June 2003</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment>95</enrollment>
  <condition>Graft Vs Host Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ABX-CBL</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Recipient of single allogeneic stem cell transplant from any donor type

          -  Time post transplant less than 100 days

          -  Received no treatment for GVHD other than steroids

        Exclusion Criteria:

          -  Recipient of second allogeneic stem cell transplant or subsequent lymphocyte product
             from the donor post transplant

          -  IBMTR index less than A

          -  Received any murine product in the past

          -  Diagnosed with chronic GVHD

          -  Received Atgam later than day 10 post transplant

          -  Change to prophylactic regimen for acute GVHD within 72 hours of randomization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Abgenix, Inc</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2003</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2002</study_first_submitted>
  <study_first_submitted_qc>May 6, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2002</study_first_posted>
  <last_update_submitted>June 23, 2005</last_update_submitted>
  <last_update_submitted_qc>June 23, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 24, 2005</last_update_posted>
  <keyword>Acute graft versus host disease</keyword>
  <keyword>Stem Cell Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graft vs Host Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

